Clover Health Investments Corp. Cl A (CLOV) News
Filter CLOV News Items
CLOV News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
CLOV News Highlights
- CLOV's 30 day story count now stands at 3.
- Over the past 16 days, the trend for CLOV's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DEC and LEE are the most mentioned tickers in articles about CLOV.
Latest CLOV News From Around the Web
Below are the latest news stories about CLOVER HEALTH INVESTMENTS CORP that investors may wish to consider to help them evaluate CLOV as an investment opportunity.
CLOV Stock Alert: Clover Health Announces CFO DepartureClover Health Investments stock is on the rise Thursday as investors in CLOV shares react to news of the company's CFO departing next month. |
Morgan Stanley Says Salesforce (CRM) Is Headed for Record HighSalesforce stock is on the rise today as investors in CRM react to an upgrade and price target increaser from a Morgan Stanley analyst. |
Why Is Smart for Life (SMFL) Stock Up 238% Today?Smart for Life stock is taking off on Thursday as SMFL investors react to news of the company preparing for a hearing meeting in March 2024. |
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023Lee A. Shapiro, Clover Audit Committee Chair, will lead the search for the next Clover CFOFRANKLIN, Tenn., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Scott J. Leffler, its Chief Financial Officer, will be leaving the Company on January 26, 2024 in order to pursue another professional opportunity. Mr. Leffl |
Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024FRANKLIN, Tenn., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that its CEO, Andrew Toy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 12:00 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor |
Clover Health Investments, Corp.'s (NASDAQ:CLOV) top owners are individual investors with 57% stake, while 23% is held by insidersKey Insights Clover Health Investments' significant individual investors ownership suggests that the key decisions are... |
Clover Health Exits ACO REACH to Accelerate Path to ProfitabilityFRANKLIN, Tenn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has delivered notice to the Centers for Medicare and Medicaid Services (“CMS”) that it will exit the CMS ACO REACH Program at the end of the 2023 performance year. Written notification will also be sent to all participating ph |
Tomorrow’s Titans: 3 Stocks Under $10 Poised for Explosive GrowthAre you looking to invest in tomorrow's titans? |
Clover Health and WellBe Senior Medical Partner to Bring In-home Medical Care to Atlanta Patients and Across Rural GeorgiaClover Health and WellBe Senior Medical have teamed up to deliver home-based medical care to residents of Georgia living with multiple complex health conditions. By providing a new option for home-based medical care, Clover is helping its members achieve their health goals with access to quality care through WellBe's in-home visits. WellBe Senior Medical puts patients first by delivering medical visits to members at their home. With just one phone call, Clover members meeting clinical eligibilit |
Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2023 Earnings Call TranscriptClover Health Investments, Corp. (NASDAQ:CLOV) Q3 2023 Earnings Call Transcript November 6, 2023 Clover Health Investments, Corp. beats earnings expectations. Reported EPS is $-0.08626, expectations were $-0.1. Operator: Ladies and gentlemen, good afternoon, and welcome to the Clover Health Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. […] |